BIC won’t get Schick
This article was originally published in The Rose Sheet
Executive Summary
BIC out of running for Pfizer's Schick-Wilkinson shaving business due to possible regulatory hurdles, BIC announces Sept. 3. BIC contacted Pfizer after shaving business was put up for sale, but the pharmaceutical giant said it would not pursue a deal with BIC because it would take longer to obtain regulatory approval than if it proceeded with other potential buyers, BIC says. BIC will move forward with plans to enter triple-blade razor category with scheduled launch of BIC Comfort 3 Shaver in first quarter 2003, firm adds. Pfizer announced its desire to divest Schick in June (1"The Rose Sheet" July 1, 2002, In Brief)...
You may also be interested in...
Pfizer seeking Schick buyer
Pfizer announces it is "exploring strategic options," including possible sale, for its Schick-Wilkinson Sword shaving products and Adams confectionery businesses. With 2001 sales of approximately $620 mil., Schick's top brands include Xtreme III razors and blades, Silk Effects, Protector and FX Diamonds. Both the Schick and Adams businesses became part of Pfizer in June 2000 with the company's merger with Warner-Lambert. Morgan Stanley will act as investment banker for Schick...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.